Author:
Bronte Enrico,Bronte Giuseppe,Novo Giuseppina,Rinaldi Gaetana,Bronte Fabrizio,Passiglia Francesco,Russo Antonio
Subject
Pharmacology (medical),Pharmacology
Reference47 articles.
1. Detection of mutations in the mitogen-activated protein kinase pathway in human melanoma;Alsina;Clinical Cancer Research,2003
2. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: A single-centre, open-label, randomised, phase 2 trial;Amaria;The Lancet Oncology,2018
3. What's new in melanoma? Combination!;Ascierto;Journal of Translational Medicine,2015
4. Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): Updated efficacy results from a randomised, double-blind, phase 3 trial;Ascierto;The Lancet Oncology,2016
5. Cardiovascular effects of the MEK inhibitor, Trametinib: A case report, literature review, and consideration of mechanism;Banks;Cardiovascular Toxicology,2017
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献